These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29295661)

  • 1. Neonatal hyperbilirubinemia secondary to combined anti e and anti C isoimmunisation: a literature review.
    Sharma D; Farahbakhsh N
    J Matern Fetal Neonatal Med; 2019 Jun; 32(12):2009-2011. PubMed ID: 29295661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated anaemia as a manifestation of Rh isoimmunisation.
    Roda J; Mimoso G; Benedito M; Pereira DF
    BMJ Case Rep; 2012 Jan; 2012():. PubMed ID: 22665873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report.
    Sarici SU; Alpay F; Yeşilkaya E; Ozcan O; Gökçay E
    Turk J Pediatr; 2002; 44(3):248-50. PubMed ID: 12405439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Anti e and Anti C Rh Isoimmunisation and Severe Hyperbilirubinemia.
    Sharma D; Dannapuneni N; Murki S; Pratap T
    Indian J Pediatr; 2015 Jun; 82(6):570. PubMed ID: 25579618
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct antiglobulin test in the prediction of hyperbilirubinemia and predischarge bilirubin levels in infants with mother-infant blood type incompatibility.
    Mehta R; Petrova A
    Pediatr Neonatol; 2021 Jul; 62(4):406-411. PubMed ID: 33967007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice].
    Sun G; Wang YL; Liang JF; Du LZ
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):848-52. PubMed ID: 18282419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe neonatal hyperbilirubinemia secondary to combined RhC hemolytic disease, congenital hypothyroidism and large adrenal hematoma: a case report.
    Dai C; Chen C; Jiang L; Zhu Y; Wang C
    BMC Pediatr; 2022 Sep; 22(1):539. PubMed ID: 36089589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of neonatal hyperbilirubinemia: pediatricians' practices and educational needs.
    Petrova A; Mehta R; Birchwood G; Ostfeld B; Hegyi T
    BMC Pediatr; 2006 Mar; 6():6. PubMed ID: 16519797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy.
    Chang PW; Kuzniewicz MW; McCulloch CE; Newman TB
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28196932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hemolytic disease of the newborn from anti-e.
    McAdams RM; Dotzler SA; Winter LW; Kerecman JD
    J Perinatol; 2008 Mar; 28(3):230-2. PubMed ID: 18309317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe conjugated hyperbilirubinaemia and neonatal haemolysis.
    Allgood C; Bolisetty S
    Int J Clin Pract; 2006 Nov; 60(11):1513-4. PubMed ID: 17073846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.
    Bhutani VK; Stark AR; Lazzeroni LC; Poland R; Gourley GR; Kazmierczak S; Meloy L; Burgos AE; Hall JY; Stevenson DK;
    J Pediatr; 2013 Mar; 162(3):477-482.e1. PubMed ID: 23043681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-test probability for neonatal hyperbilirubinemia based on umbilical cord blood bilirubin, direct antiglobulin test, and ABO compatibility results.
    Peeters B; Geerts I; Van Mullem M; Micalessi I; Saegeman V; Moerman J
    Eur J Pediatr; 2016 May; 175(5):651-7. PubMed ID: 26782094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia.
    Elhawary IM; Abdel Ghany EAG; Aboelhamed WA; Ibrahim SGE
    World J Pediatr; 2018 Aug; 14(4):350-356. PubMed ID: 29464578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rh Alloimmunisation: Current Updates in Antenatal and Postnatal Management.
    Sahoo T; Sahoo M; Gulla KM; Gupta M
    Indian J Pediatr; 2020 Dec; 87(12):1018-1028. PubMed ID: 32607667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
    Keren R; Luan X; Friedman S; Saddlemire S; Cnaan A; Bhutani VK
    Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-M antibodies as a cause of intrauterine fetal death and neonatal hyperbilirubinaemia.
    Sharma D; Murki A; Murki S; Pratap T
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24810454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early neonatal hyperbilirubinemia using first day serum bilirubin level.
    Agarwal R; Kaushal M; Aggarwal R; Paul VK; Deorari AK
    Indian Pediatr; 2002 Aug; 39(8):724-30. PubMed ID: 12196683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-6-phosphate dehydrogenase deficiency in neonatal indirect hyperbilirubinemia.
    Atay E; Bozaykut A; Ipek IO
    J Trop Pediatr; 2006 Feb; 52(1):56-8. PubMed ID: 15917260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.